---
created: 2025-04-13
updated: 2025-04-13T10:53
id: DWz(JXSwkS
specialty: pharmaco
specialty_id: 482
tags:
  - source/ak-original-decks::step-1::lolnotacop::drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::20-sorafenib-sunitinib
  - "source/ak-step1-v11:": 
  - theme/ome::06-inflammation-neoplasia::08-cycle-chemo
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::03-kinase-inhibitors-&-monoclonal-antibodies::01-imatinib,-erlotinib,-sorafenib,-sunitinib,-vemurafenib"
type: flashcard
---

# Question
**Sunitinib** and **sorafenib** are small molecules that inhibit the **VEGFR tyrosine kinase**

---

# Answer
VEGFR = vascular endothelial growth factor receptor (a tyrosine kinase)